Based on this logic MCU should get twice as much. They work with B6 coenzyme Pyridoxal-5-phosphate. They target only acute and chronic heart problems, cholesterol, high blood pressure and diabetes. They also said from the beginning that they micmic KOSP's business plan. I think the double is a modest goal.